Our current study’s findings are consistent with our previous research [33], further substantiating that the FOS and JUN genes serve as potential molecular markers for diagnosing thyroid malignancies, particularly follicular thyroid carcinoma (FTC). This evidence concerns the gene JUN and thyroid gland disorder.